Jade Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2025 | 4.89 M | $42.19 M | 1.10% | 12.35% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2025 | 3.22 M | $27.79 M | 0.00% | 8.14% |
| VR ADVISER, LLC | 11/14/2025 | 3.22 M | $27.79 M | 0.00% | 8.14% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 2.28 M | $19.68 M | -9.14% | 5.76% |
| BLACKROCK, INC. | 11/12/2025 | 2.15 M | $18.56 M | 25.42% | 5.43% |
| VANGUARD GROUP INC | 11/07/2025 | 1.73 M | $14.90 M | -4.47% | 4.36% |
| VERSANT VENTURE MANAGEMENT, LLC | 11/10/2025 | 1.53 M | $13.17 M | 0.00% | 3.85% |
| RTW INVESTMENTS, LP | 11/14/2025 | 1.45 M | $12.51 M | 0.00% | 3.66% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 1.41 M | $12.20 M | -20.25% | 3.57% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.26 M | $10.84 M | 0.00% | 3.17% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2025 | 1.13 M | $9.73 M | 0.00% | 2.85% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 1.06 M | $9.17 M | 0.00% | 2.68% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 796.74 K | $6.88 M | 0.00% | 2.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 665.92 K | $5.75 M | -1.55% | 1.68% |
| GREAT POINT PARTNERS LLC | 11/14/2025 | 632.60 K | $5.46 M | 27.01% | 1.60% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 625.00 K | $5.39 M | 0.00% | 1.58% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 531.16 K | $4.58 M | 0.00% | 1.34% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 531.16 K | $4.58 M | 0.00% | 1.34% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2025 | 531.16 K | $4.58 M | 0.00% | 1.34% |
| STATE STREET CORP | 11/14/2025 | 499.29 K | $4.31 M | 56.63% | 1.26% |
| NORTHERN TRUST CORP | 11/14/2025 | 229.58 K | $1.98 M | 0.65% | 0.58% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 162.71 K | $1.40 M | 100.00% | 0.41% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 107.55 K | $928.18 K | 100.00% | 0.27% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 107.39 K | $926.78 K | 0.00% | 0.27% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 93.25 K | $804.75 K | -9.69% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 82.35 K | $710.69 K | 5.05% | 0.21% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 65.32 K | $563.69 K | 0.00% | 0.17% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 57.30 K | $494.50 K | -1.72% | 0.14% |
| MORGAN STANLEY | 11/14/2025 | 54.24 K | $468.10 K | 8.98% | 0.14% |
| BARCLAYS PLC | 11/12/2025 | 45.77 K | $394.97 K | -83.35% | 0.12% |
| RHUMBLINE ADVISERS | 11/06/2025 | 42.78 K | $369.22 K | -4.01% | 0.11% |
| NUVEEN, LLC | 11/12/2025 | 42.75 K | $368.92 K | -28.91% | 0.11% |
| XTX TOPCO LTD | 11/14/2025 | 40.30 K | $347.76 K | 56.48% | 0.10% |
| MARSHALL WACE, LLP | 11/13/2025 | 38.08 K | $328.63 K | 100.00% | 0.10% |
| INVESCO LTD. | 11/13/2025 | 34.58 K | $298.39 K | 100.00% | 0.09% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 29.60 K | $255.41 K | 15.55% | 0.07% |
| QUANTINNO CAPITAL MANAGEMENT LP | 11/14/2025 | 26.98 K | $232.79 K | 22.69% | 0.07% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 24.87 K | $214.63 K | 19.38% | 0.06% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 24.61 K | $212.38 K | 100.00% | 0.06% |
| UBS GROUP AG | 11/13/2025 | 19.83 K | $171.14 K | -5.74% | 0.05% |
| JPMORGAN CHASE & CO | 11/26/2025 | 13.20 K | $113.90 K | -14.11% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 17.65 K | $152.35 K | -55.00% | 0.04% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 16.26 K | $141.00 K | 0.00% | 0.04% |
| DELTEC ASSET MANAGEMENT LLC | 10/24/2025 | 15.76 K | $135.97 K | 0.00% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2025 | 15.22 K | $131.37 K | -14.28% | 0.04% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 14.93 K | $128.86 K | 363.41% | 0.04% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 14.58 K | $125.83 K | 1.60% | 0.04% |
| INTECH INVESTMENT MANAGEMENT LLC | 11/12/2025 | 14.12 K | $121.87 K | -38.59% | 0.04% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2025 | 13.28 K | $114.64 K | 100.00% | 0.03% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 12.05 K | $104.03 K | 0.00% | 0.03% |
Jade Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 78 institutional investors and hedge funds held shares of Jade Biosciences, Inc.. The most heavily invested institutionals were:
FMR LLC: 4.89 M
Fairmount Funds Management LLC: 3.22 M
VR Adviser, LLC: 3.22 M
Deep Track Capital, LP: 2.28 M
BlackRock, Inc.: 2.15 M
VANGUARD GROUP INC: 1.73 M
79.87% of Jade Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 31.62 M shares in the last 24 months. This purchase volume represents approximately $392.05 M in transactions.